Hemophilia
Hemophilia
FOR EACH DISEASE, TRIO DEVELOPS A CUSTOM SOLUTION THAT CAPTURES PATIENT LEVEL DATA THROUGHOUT THE PATIENT JOURNEY, ALL IN REAL-TIME. TRIO’S COVERAGE INCLUDES APPROVED DRUG REGIMENS, PHYSICIANS AND PHARAMACIES WITHOUT BIAS.
Data Elements
DEMOGRAPHICS
- Diagnosis
- Age
- Gender
- Race / Ethnicity
- BMI
- Height / Weight
PT CHARACTERISTICS
- Hemophilia Severity
- IV Access Method
- Target Joints
- Prophylaxis vs. Breakthrough Bleeding Products
- Inhibitor Use
- Last Bleed Date
- Number of Bleeds
PRIOR HISTORY
- First Diagnosis of Hemophilia Date
- Prior Regimen
- Prior Treatment Status (new to therapy or refill)
- Duration of Therapy
- Reason for Switch
PT ADHERENCE
- Current Therapy
- Duration
- Dose
- Prophylaxis Product Use
- Bleeding Product Use
- % Doses Taken
- % Doses Missed
PROVIDERS
- Type (Physician, NP, PA)
- Specialty
- Academic vs Community
- Specialty Pharmacy vs. Hemophilia Treatment Center
PAYERS
- Type (Commercial, Medicare, Medicaid, Dual Eligible)
- Payer Name
- Self-Pay and Patient Assistance
- Eligibility
- Correct PA form
- Denial Reason
PA TIMELINE
- Copay Amount
- PA Submitted Date
- Approval / Denial Date
- Appeals Submitted
DISPENSING INFO
- Current Treatment Regimen Rx
- Intended Regimen
- Actual Regimen
- Duration
- Dispensed Regimen
- Duration / Refills
- Gaps in Therapy
Publications
2018
A Retrospective, Observational Study of BAX 855 in Clinical Practice in the United States
J. Booth, M. Watt, S. Milligan, L. Aledort
Poster Presented at: Academy of Managed Care Pharmacy (AMCP)
Conference dates: April 23, 2018 - April 26, 2018
